J Cardiovasc Electrophysiol. 2012 Nov;23(11):1179-84. doi: 10.1111/j.1540-8167.2012.02377.x. Epub 2012 Jun 14.
Catheter ablation of left posterior fascicular (LPF) ventricular tachycardia (VT) is commonly performed during tachycardia. This study reports on the long-term outcome of patients undergoing ablation of LPF VT targeting the earliest retrograde activation within the posterior Purkinje fiber network during sinus rhythm (SR).
This study retrospectively analyzed 24 consecutive patients (8 female; mean age 26 ± 11 years) referred for catheter ablation of electrocardiographically documented LPF VT. Programmed stimulation was performed to induce tachycardia, while mapping and ablation was aided by use of a 3D electroanatomical mapping system. Catheter ablation targeted the earliest potential suggestive of retrograde activation within the posterior Purkinje fiber network (retro-PP) recorded along the posterior mid-septal left ventricle during SR if LPF VT was noninducible.
Overall, 21/24 (87.5%) patients underwent successful catheter ablation in SR targeting the earliest retro-PP, while 3/24 (12.5%) patients were successfully ablated during tachycardia. In none of the patients, ablation resulted in LPF block. No procedure-related complications occurred. After a median follow-up period of 8.9 (4.8-10.9) years, 22/24 (92%) patients were free from recurrent VT.
In patients presenting with LPF VT, ablation of the earliest retro-PP along the posterior mid-septal LV during SR results in excellent long-term outcome during a median follow-up period of almost 9 years.
在心动过速期间,通常对左后间隔(LPF)室性心动过速(VT)进行导管消融。本研究报告了在窦性节律(SR)下针对后浦肯野纤维网络中最早逆行激活进行消融的 LPF VT 患者的长期结果。
本研究回顾性分析了 24 例连续患者(8 名女性;平均年龄 26 ± 11 岁),这些患者因心电图记录的 LPF VT 而行导管消融。在进行心动过速诱发时进行程控刺激,同时使用三维电解剖标测系统辅助进行标测和消融。如果 LPF VT 不可诱发,则针对 SR 期间记录的后间隔左心室中后部最早的提示逆行激活的电位进行消融(逆行-PP)。
总体而言,21/24(87.5%)例患者在 SR 时针对最早的逆行-PP 成功进行了导管消融,而 3/24(12.5%)例患者在心动过速时成功消融。在没有患者中,消融导致 LPF 阻滞。没有发生与手术相关的并发症。在中位数为 8.9(4.8-10.9)年的随访后,22/24(92%)例患者无复发性 VT。
在患有 LPF VT 的患者中,在 SR 期间针对后间隔左心室中后部最早逆行-PP 的消融可在近 9 年的中位随访期间获得极佳的长期结果。